机译:Evaluation of early efficacy endpoints for proof-of-concept trials
Merck and Co. Inc., UG1C46, PO Box 1000, North Wales, PA 19454-1019, United States;
Department of Statistics, Ohio State University, Columbus, OH, United States;
Benefit-cost ratio; Decision analysis; Expected power; Oncology;